Harlow John B. Jr. 4
4 · Esperion Therapeutics, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Harlow John B. Jr.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-12-04+424,536→ 424,536 total - Award
Stock Option (right to buy)
2025-12-04+380,000→ 380,000 totalExercise: $3.79Exp: 2035-12-04→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the respective one year anniversary of the vesting commencement date of December 15, 2025 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter.